The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2006

Conditions
Asthma
Interventions
DRUG

fluticasone

fluticasone (100 microgram twice daily) treatment

DRUG

montelukast

Montelukast (5 or 10 mg each night).

DRUG

Fluticasone plus salmeterol

fluticasone (100 microgram) plus salmeterol (50 microgram) each night

Trial Locations (19)

10016

New York Consortium (New York Univ. and Columbia Univ.), New York

10595

New York Medical College, Valhalla

11040

Long Island Jewish Hospital (and North Shore Hospital), New Hyde Park

19107

Thomas Jefferson Hospital, Philadelphia

27710

Duke University School of Medicine, Durham

30322

Emory University, Atlanta

32207

Nemour's Childrens Center, Jacksonville

33136

University of Miami (and University of South Florida in Tampa), Miami

35233

University of Alabama at Birmingham, Birmingham

43210

Ohio State University, Columbus

46202

Indiana University, Indianapolis

55455

University of Minnesota, Minneapolis

60611

Illinois Consortium (Northwestern, Univ. of Chicago, Univ. of Illinois), Chicago

63110

Washington University, St Louis

64108

University of Missouri at Kansas City, Kansas City

70112

Louisiana State University, New Orleans

77030

Baylor College of Medicine, Houston

80206

National Jewish Hospital, Denver

05405

Northern New England Consortium (Univ. of Vermont and other locations), Burlington

Sponsors
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

JHSPH Center for Clinical Trials

OTHER